Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VF Interim / Quarterly Report 2020

Sep 23, 2021

52431_rns_2021-09-23_4bd25e5e-ccbe-4007-8cdb-2daee4b385ac.html

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

公開資訊觀測站

合併權益變動表

本資料由望隼公司提供

「投資人若需了解更詳細資訊可至XBRL資訊平台電子書查詢
本公司採 月制會計年度(空白表曆年制)

本期

| 民國109年度 | | | | | | | | | | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 單位:新台幣仟元 | | | | | | | | | | | | | | | | | | | | | | |
| 會計項目 | 普通股股本 | 股本合計 | 資本公積 | 未分配盈餘(或待彌補虧損) | 保留盈餘合計 | 國外營運機構財務報表換算之兌換差額 | 其他權益項目合計 | 庫藏股票 | 歸屬於母公司業主之權益總計 | 非控制權益 | 權益總額 |
| 期初餘額 | 495,617 | 495,617 | 474,234 | -111,940 | -111,940 | -5,627 | -5,627 | | 852,284 | 163,163 | 1,015,447 |
| 因受領贈與產生者 | 0 | 0 | 1,800 | 0 | 0 | 0 | 0 | | 1,800 | 0 | 1,800 |
| 本期淨利(淨損) | 0 | 0 | 0 | 146,368 | 146,368 | 0 | 0 | | 146,368 | 3,707 | 150,075 |
| 本期其他綜合損益 | 0 | 0 | 0 | 0 | 0 | 7,040 | 7,040 | | 7,040 | 6,741 | 13,781 |
| 本期綜合損益總額 | 0 | 0 | 0 | 146,368 | 146,368 | 7,040 | 7,040 | | 153,408 | 10,448 | 163,856 |
| 實際取得或處分子公司股權價格與帳面價值差額 | 0 | 0 | -92 | 0 | 0 | 0 | 0 | | -92 | 0 | -92 |
| 股份基礎給付 | 4,460 | 4,460 | 19 | 0 | 0 | 0 | 0 | | 4,479 | 0 | 4,479 |
| 非控制權益增減 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 | 107,778 | 107,778 |
| 權益增加(減少)總額 | 4,460 | 4,460 | 1,727 | 146,368 | 146,368 | 7,040 | 7,040 | | 159,595 | 118,226 | 277,821 |
| 期末餘額 | 500,077 | 500,077 | 475,961 | 34,428 | 34,428 | 1,413 | 1,413 | | 1,011,879 | 281,389 | 1,293,268 |

去年同期

| 民國108年度 | | | | | | | | | | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 單位:新台幣仟元 | | | | | | | | | | | | | | | | | | | | | | |
| 會計項目 | 普通股股本 | 股本合計 | 資本公積 | 未分配盈餘(或待彌補虧損) | 保留盈餘合計 | 國外營運機構財務報表換算之兌換差額 | 其他權益項目合計 | 庫藏股票 | 歸屬於母公司業主之權益總計 | 非控制權益 | 權益總額 |
| 期初餘額 | 367,387 | 367,387 | 259,230 | -232,259 | -232,259 | -2,153 | -2,153 | | 392,205 | 73,650 | 465,855 |
| 本期淨利(淨損) | 0 | 0 | 0 | 120,319 | 120,319 | 0 | 0 | | 120,319 | -29,948 | 90,371 |
| 本期其他綜合損益 | 0 | 0 | 0 | 0 | 0 | -3,474 | -3,474 | | -3,474 | -2,721 | -6,195 |
| 本期綜合損益總額 | 0 | 0 | 0 | 120,319 | 120,319 | -3,474 | -3,474 | | 116,845 | -32,669 | 84,176 |
| 現金增資 | 120,000 | 120,000 | 216,000 | 0 | 0 | 0 | 0 | | 336,000 | 0 | 336,000 |
| 實際取得或處分子公司股權價格與帳面價值差額 | 0 | 0 | -1,043 | 0 | 0 | 0 | 0 | | -1,043 | 0 | -1,043 |
| 股份基礎給付 | 8,230 | 8,230 | 47 | 0 | 0 | 0 | 0 | | 8,277 | 0 | 8,277 |
| 非控制權益增減 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 | 122,182 | 122,182 |
| 權益增加(減少)總額 | 128,230 | 128,230 | 215,004 | 120,319 | 120,319 | -3,474 | -3,474 | | 460,079 | 89,513 | 549,592 |
| 期末餘額 | 495,617 | 495,617 | 474,234 | -111,940 | -111,940 | -5,627 | -5,627 | | 852,284 | 163,163 | 1,015,447 |